重组人突触融合蛋白7(Syntaxin-7)供应

特别声明：本产品及我公司所售其他产品均为科研类试剂产品，严禁用于药物、医疗及其他非科研用途。

北京百奥莱博主要从事生物试剂的生产和销*(代"售")，产品线涵盖重组人突触融合蛋白7(Syntaxin-7)供应在内的分子生物学试剂产品，还包括PCR及荧光定量PCR、核酸提取试剂盒类、样本核酸保护试剂、核酸提取、克隆与转化、蛋白纯化、蛋白检测、免疫组化、细胞凋亡与抗体等。

名称：重组人突触融合蛋白7(Syntaxin-7)供应
编号：JN1443
规格：10μg|50μg|500μg|1mg
英文名：Recombinant Human Syntaxin-7
品牌：百奥莱博
产地：北京
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ser2-Leu238在N端含有His标签。

Syntaxin-7质量控制：＞95%(还原性SDS-PAGE)

Syntaxin-7制剂：冻干品

Syntaxin-7保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

Syntaxin-7复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于Syntaxin-7：
Syntaxin 7 (STX7) is a member of a family of membrane-trafficking proteins named as soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), and mediates the endo*(代"c")ytic trafficking from early endosomes to late endosomes and lysosomes. Syntaxin-7 has been shown to be present in both late endosomes and lysosomes, and to be required for both homotypic late endosome fusion and heterotypic fusion with lysosomes. STX7 has been shown to interact with STX8, VPS18, Vesicle-associated membrane protein 8 and VPS11.

重组人突触融合蛋白7(Syntaxin-7)供应极具性价比，此外，我公司正火爆促销以下产品：

·重组人巨噬细胞迁移抑制因子(MIF)
编号：JN1188
英文名称：Recombinant Human Macrophage migration inhibitory factor
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Met1-Ala115表达纯化得来。

MIF质量控制：＞95%(还原性SDS-PAGE)

MIF制剂：液体

MIF保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。

关于MIF：
Human MIF is a 12.5 kDa, 115 amino acid (aa) nonglycosylated polypeptide that is synthesized without asignal sequence .Secretion occurs nonclassically via an ABCA1 transporter.Pro-inflammatory cytokine.Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites ofinflammation suggests a role as mediator in regulating the function of acrophages in host defense.Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase anddopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clearwhether the tautomerase activity has any physiological relevance, and whether it is important for cytokineactivity.


重组人突触融合蛋白7(Syntaxin-7)供应关键词：JN1443,重组人突触融合蛋白7,重组突触融合蛋白7,重组人Syntaxin-7,重组人突触融合蛋白7蛋白


·重组人Jagged-1蛋白(JAG1)
编号：JN1088
英文名称：Recombinant Human jagged-1
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Gln34-Ser1046在C端带有Fc标签。

JAG1质量控制：＞95%(还原性SDS-PAGE)

JAG1制剂：冻干品

JAG1保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

JAG1复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于JAG1：
Protein jagged-1 I, also known as Jagged-1, JAGL1, HJ1, JAG1 and CD339, is a single-pass type I membrane protein.JAG1 contains one DSL domain and sixteen EGF-like domain. JAG1 acts as a ligand for multiple Notch receptors and is involved in the mediation of Notch signaling. JAG1 may participate in early and late stages of mammalian cardiovascular development, JAG1 inhibits myoblast differentiation and enhances fibroblast growth factor-induced angiogenesis. Defects in JAG1 are the cause of Alagille syndrome type 1, which is autosomal dominant multisystem disorder defined clinically by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations.


重组人突触融合蛋白7(Syntaxin-7)供应关键词：JN1443,重组人突触融合蛋白7,重组突触融合蛋白7,重组人Syntaxin-7,重组人突触融合蛋白7蛋白


·重组人CDK4抑制剂C(CDKN2C)
编号：JN2013
英文名称：Recombinant Human Cyclin-Dependent Kinase 4 Inhibitor C
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Met1-Gln168在N端含有His标签。

CDKN2C质量控制：＞95%(还原性SDS-PAGE)

CDKN2C制剂：冻干品

CDKN2C保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

CDKN2C复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于CDKN2C：
Cyclin-Dependent Kinase 4 Inhibitor C (CDKN2C) is a member of the INK4 family of cyclin dependent kinase inhibitors. CDKN2C contains 4 ANK repeats and interacts with CDK4 or CDK6. Highest levels of CDKN2C can be found in skeletal muscle, pancreas, and heart. CDKN2C inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB and prevent the activation of the CDK kinases. Studies have been shown the roles of CDKN2C gene in regulating spermatogenesis, as well as in suppressing tumorigenesis.

我公司生产供应销*(代"售")的重组蛋白产品正全系列现货促销，满分期待您的垂询选购重组人突触融合蛋白7(Syntaxin-7)供应。